Report Summary
Eternity Insights has published a new study on Global Transforming Growth Factor Beta 1 Market focusing on key segments as by Type (Pirfenidone,Galunisertib,Others), by Application (IPF,Cancer,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Transforming Growth Factor Beta 1 Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Transforming Growth Factor Beta 1 Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Transforming Growth Factor Beta 1 Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Transforming Growth Factor Beta 1 Market Segmentation:
Transforming Growth Factor Beta 1 Market, By Type
- Pirfenidone
- Galunisertib
- Others
Transforming Growth Factor Beta 1 Market, By Application
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Transforming Growth Factor Beta 1 market in terms of demand generation. The Transforming Growth Factor Beta 1 market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Transforming Growth Factor Beta 1 market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Transforming Growth Factor Beta 1 Market Taxonomy:
To learn more about this report
Global Transforming Growth Factor Beta 1 Market Competitive Landscape
The global Transforming Growth Factor Beta 1 market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Roche
- Shionogi Ltd
- Acceleron Pharma Inc
- Genzyme Corp
- Isarna Therapeutics GmbH
- Scholar Rock
- Sirnaomics Inc
- Eli Lilly and Co
- Formation Biologics Inc
- Novartis AG
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Pirfenidone,Galunisertib,Others |
| By Application Outlook |
IPF,Cancer,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Roche,Shionogi Ltd,Acceleron Pharma Inc,Genzyme Corp,Isarna Therapeutics GmbH,Scholar Rock,Sirnaomics Inc,Eli Lilly and Co,Formation Biologics Inc,Novartis AG |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Transforming Growth Factor Beta 1 Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Transforming Growth Factor Beta 1 Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Transforming Growth Factor Beta 1 Industry Overview
2.1 Global Transforming Growth Factor Beta 1 Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Transforming Growth Factor Beta 1 Global Import Market Analysis
2.1.2 Transforming Growth Factor Beta 1 Global Export Market Analysis
2.1.3 Transforming Growth Factor Beta 1 Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3.2 Cancer
2.3.3 Others
2.4.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Transforming Growth Factor Beta 1 Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Transforming Growth Factor Beta 1 Manufacturer Market Share
2.4.5 Top 10 Transforming Growth Factor Beta 1 Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Transforming Growth Factor Beta 1 Market
2.4.7 Key Manufacturers Transforming Growth Factor Beta 1 Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Transforming Growth Factor Beta 1 Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Transforming Growth Factor Beta 1 Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Transforming Growth Factor Beta 1 Market Size Categorized by Regions
4.1 Global Transforming Growth Factor Beta 1 Revenue, Sales and Market Share by Regions
4.1.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Regions (2015-2020)
4.2 Europe Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
4.3 APAC Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
4.4 North America Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
4.5 South America Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5 Europe Transforming Growth Factor Beta 1 Market Size Categorized by Countries
5.1 Europe Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
5.1.1 Europe Transforming Growth Factor Beta 1 Sales by Countries (2015-2020)
5.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Countries (2015-2020)
5.1.3 Germany Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5.1.4 UK Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5.1.5 France Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5.1.6 Russia Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5.1.7 Italy Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5.1.8 Spain Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
5.2 Europe Transforming Growth Factor Beta 1 Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
5.3.2 Europe Transforming Growth Factor Beta 1 Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
6 Asia-Pacific Transforming Growth Factor Beta 1 Market Size Categorized by Countries
6.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Countries (2015-2020)
6.1.3 China Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
6.1.4 Japan Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
6.1.5 Korea Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
6.1.6 India Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
6.1.8 Australia Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Transforming Growth Factor Beta 1 Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Transforming Growth Factor Beta 1 Sales and Market Share by Application (2015-2020)
7 North America Transforming Growth Factor Beta 1 Market Size Categorized by Countries
7.1 North America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
7.1.1 North America Transforming Growth Factor Beta 1 Sales by Countries (2015-2020)
7.1.2 North America Transforming Growth Factor Beta 1 Revenue by Countries (2015-2020)
7.1.3 United States Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
7.1.4 Canada Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
7.1.5 Mexico Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
7.2 North America Transforming Growth Factor Beta 1 Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
7.3.2 North America Transforming Growth Factor Beta 1 Revenue and Revenue Share by Type (2015-2020)
7.4 North America Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
8 South America Transforming Growth Factor Beta 1 Market Size Categorized by Countries
8.1 South America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
8.1.1 South America Transforming Growth Factor Beta 1 Sales by Countries (2015-2020)
8.1.2 South America Transforming Growth Factor Beta 1 Revenue by Countries (2015-2020)
8.1.3 Brazil Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
8.2 South America Transforming Growth Factor Beta 1 Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
8.3.2 South America Transforming Growth Factor Beta 1 Revenue and Revenue Share by Type (2015-2020)
8.4 South America Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
9 Middle East and Africa Transforming Growth Factor Beta 1 Market Size Categorized by Countries
9.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Countries (2015-2020)
9.1.3 GCC Countries Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
9.1.4 Turkey Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
9.1.5 Egypt Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
9.1.6 South Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
10 Global Transforming Growth Factor Beta 1 Market Segment by Type
10.1 Global Transforming Growth Factor Beta 1 Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Type (2015-2020)
10.1.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2015-2020)
10.2 Pirfenidone Sales Growth Rate and Price
10.2.1 Global Pirfenidone Sales Growth Rate (2015-2020)
10.2.2 Global Pirfenidone Price (2015-2020)
10.3 Galunisertib Sales Growth Rate and Price
10.3.1 Global Galunisertib Sales Growth Rate (2015-2020)
10.3.2 Global Galunisertib Price (2015-2020)
10.4 Others Sales Growth Rate and Price
10.4.1 Global Others Sales Growth Rate (2015-2020)
10.4.2 Global Others Price (2015-2020)
11.1 Global Transforming Growth Factor Beta 1Sales Market Share by Application (2015-2020)
11.2 IPF Sales Growth Rate (2015-2020)
11.3 Cancer Sales Growth Rate (2015-2020)
11.4 Others Sales Growth Rate (2015-2020)
12.1 Global Transforming Growth Factor Beta 1 Revenue, Sales and Growth Rate (2020-2027)
12.2 Transforming Growth Factor Beta 1 Market Forecast by Regions (2020-2027)
12.2.1 Europe Transforming Growth Factor Beta 1 Market Forecast (2020-2027)
12.2.2 APAC Transforming Growth Factor Beta 1 Market Forecast (2020-2027)
12.2.3 North America Transforming Growth Factor Beta 1 Market Forecast (2020-2027)
12.2.4 South America Transforming Growth Factor Beta 1 Market Forecast (2020-2027)
12.2.5 Middle East & Africa Transforming Growth Factor Beta 1 Market Forecast (2020-2027)
12.3 Transforming Growth Factor Beta 1 Market Forecast by Type (2020-2027)
12.3.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2020-2027)
12.3.2 Global Transforming Growth Factor Beta 1 Market Share Forecast by Type (2020-2027)
12.4 Transforming Growth Factor Beta 1 Market Forecast by Application (2020-2027)
12.4.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2020-2027)
12.4.2 Global Transforming Growth Factor Beta 1 Market Share Forecast by Application (2020-2027)
13 Analysis of Transforming Growth Factor Beta 1 Industry Key Manufacturers
13.1 Roche
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Roche Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Roche News
13.2 Shionogi Ltd
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Shionogi Ltd News
13.3 Acceleron Pharma Inc
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Acceleron Pharma Inc News
13.4 Genzyme Corp
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Genzyme Corp News
13.5 Isarna Therapeutics GmbH
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Isarna Therapeutics GmbH News
13.6 Scholar Rock
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Scholar Rock Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Scholar Rock News
13.7 Sirnaomics Inc
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Sirnaomics Inc News
13.8 Eli Lilly and Co
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Eli Lilly and Co News
13.9 Formation Biologics Inc
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Formation Biologics Inc News
13.10 Novartis AG
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Novartis AG Transforming Growth Factor Beta 1 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Novartis AG News
15 Appendix
